Las Vegas, NV -- (SBWIRE) -- 10/21/2013 -- Beststocksondemand.com is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds works diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies: Acacia Research Corp (NASDAQ:ACTG), pSivida Corp. (NASDAQ:PSDV),Knightsbridge Tankers Limited (NASDAQ:VLCCF), Immunomedics, Inc. (NASDAQ:IMMU).
Acacia Research Corp (NASDAQ:ACTG) decreased -21.10% and closed at $15.48 on a traded volume of 7.74 million shares, in comparison to 681.840 shares of average trading volume.
The company has a total market capitalization of $772.19 million and its total outstanding shares are 49.88 million. Acacia Research Corporation, through its subsidiaries, acquires, develops, licenses, and enforces patented technologies in the United States.
Will ACTG Get Buyers Even After The Recent Rally? Find Out Here
pSivida Corp. (NASDAQ:PSDV) plunged -24.47% and closed at $2.87 on a traded volume of 4.35 million shares, whereas its average trading volume is 982.129 shares. The Intra-day range for the stock is $2.30 and $3.16. pSivida Corp. develops products to deliver drugs and biologics primarily in the United States and the United Kingdom.
Will PSDV Get Buyers Even After The Recent Rally? Find Out Here
Knightsbridge Tankers Limited (NASDAQ:VLCCF) dropped -17.21% and closed at $8.61. The 52-week range for the stock is $4.94 and $10.69 and during the previous trading session the stock touched its highest price at $8.85. Its introductory price for the day was $8.79, with the overall traded volume of 33.76M shares. Knightsbridge Tankers Limited is engaged in the seaborne transportation of crude oil and dry bulk cargoes. As of December 31, 2011, the Company owned and operated, through its subsidiaries, a fleet of eight vessels, consisted of four very large crude carriers (VLCCs) and four Capesize dry bulk carriers with a total carrying capacity of approximately 1.9 million deadweight ton.
Will VLCCF Get Buyers Even After The Recent Rally? Find Out Here
Immunomedics, Inc. (NASDAQ:IMMU) after opening its trade at the price of $5.13, dropped -11.56% to close at $4.47 for the day. The stock moved on a traded volume of 3.12 million shares, in comparison to 1.20 million shares of average trading volume. The 52-week range for the stock is $2.11 and $7.35 and during the previous trading session the stock touched its highest price at $5.19. Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other serious diseases.
Will IMMU Get Buyers Even After The Recent Rally? Find Out Here
About: Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock reader, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wall Street. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)